陈锦超,王 华.T1期膀胱癌行二次电切的意义及后续治疗的选择[J].中国肿瘤,2017,26(12):982-985.
T1期膀胱癌行二次电切的意义及后续治疗的选择
The Role of Repeat Transurethral Resection in T1 Bladder Tumor and the Choice of Following Strategies of Treatment
投稿时间:2017-07-27  
DOI:10.11735/j.issn.1004-0242.2017.12.A011
中文关键词:  膀胱肿瘤  二次电切  预后
英文关键词:bladder neoplasms  repeat transurethral resection  prognosis
基金项目:
作者单位
陈锦超 浙江省肿瘤医院 
王 华 浙江省肿瘤医院 
摘要点击次数: 1938
全文下载次数: 525
中文摘要:
      摘 要:二次电切应用于T1期膀胱癌,可以纠正首次电切的错误分期、清除残留肿瘤组织,而且减少膀胱肿瘤的复发和进展。T1期膀胱癌二次电切的阳性率与首次电切时的肿瘤特点(肿瘤分级、肿瘤大小、肿瘤数量)相关。T1期膀胱癌二次电切阳性发现(首次电切的肿瘤残留)不利于预后,分期高的预后差。需要根据二次电切时不同的病理分期制定不同的治疗策略,对于T0、Ta、Tis期需行bacillus Calmette-Guérin (BCG)灌注,T1期尽早实施膀胱全切可能会获益,T2期及以上应积极实施膀胱全切。
英文摘要:
      Abstract:Repeat transurethral resection(Re-TUR) is indicated for T1 bladder tumors. A re-TUR can reduce a significant percentage of residual tumors,detect muscle invasive disease,and significantly decrease the recurrence and progression rates. The rate of positive findings of re-TUR (residual tumors) is associated with the characteristics of bladder tumors at primary TUR,such as tumor size,tumor grade and tumor number. Furthermore,the positive findings indicate worse prognosis. Different strategies of treatment should be made according to the different findings at re-TUR. For patients with T0,Ta and Tis tumors at re-TUR,intravesical bacillus Calmette-Guérin (BCG) immunotherapy is needed. For patients with T1 at re-TUR,early cystectomy may benefit,and patients with more than T2 bladder tumors at re-TUR should receive cystectomy immediately.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器